SCHEMBL2990099

SCHEMBL2990099

CC(C)C(C)(c1ccc(OCc2nccs2)cc1)c1ccc(-c2nnn(C(F)F)n2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
NPSR1 Q6W5P4 2/20 0.40
LTA4H P09960 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.36
NFKB1 P19838 1/20 0.36
NFKB2 Q00653 1/20 0.36
RELA Q04206 1/20 0.36
ACACB O00763 1/20 0.36
MAOB P27338 1/20 0.34
ALOX5AP P20292 1/20 0.34
PDE10A Q9Y233 1/20 0.34
RECQL P46063 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.34
HPGD P15428 1/20 0.34
MAPK1 P28482 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3000148 0.89 AOC3 (0.41) NPC1RAB9ANPSR1SMN1; SMN2MAOB
SCHEMBL2995628 0.88 NPC1 (0.46) NPC1RAB9ANPSR1SMN1; SMN2NFKB1
SCHEMBL2997565 0.84 NPC1 (0.50) NPC1RAB9ANPSR1LTA4HCYP2D6
SCHEMBL3002980 0.77 APP (0.45) RAB9ALTA4HACACBALOX5AP
SCHEMBL2999090 0.76 ALOX5AP (0.48) NPC1RAB9ASMN1; SMN2ACACBALOX5AP
SCHEMBL3000902 0.75 ALOX5AP (0.43) NPC1RAB9ASMN1; SMN2ACACBALOX5AP
SCHEMBL2993269 0.75 NR4A2 (0.49) NPC1RAB9ASMN1; SMN2ACACBMAPK1
SCHEMBL3000188 0.75 ACACB (0.46) RAB9AACACBMAOBALOX5APALDH1A1
Ammonia Solution, Strong SCHEMBL2997486 0.74 ACACB (0.37) ACACBALOX5AP
SCHEMBL2995463 0.74 AOC3 (0.39) CYP2D6ACACBALOX5APAOC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2546232-A1 Diphenyl Substituted Alkanes Merck Sharp & Dohme Corp. (US) 2013-01-16 EP disclosed
US-20100190761-A1 DIPHENYL SUBSTITUTED ALKANES MERCK SHARP & DOHME CORP. 2010-07-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100190761-A1 DIPHENYL SUBSTITUTED ALKANES ALOX5, ALOX15, ALOX15B NPC1 603/4885RAB9A 4316/4885NPSR1 1021/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.